Myelostat

🧾 Product Overview Table

🧬 Introduction to Hydroxyurea (Myelostat 500 mg)
Hydroxyurea is a well-established antimetabolite used for the treatment of certain types of cancer and blood disorders. Myelostat 500 mg by Zydus Cadila is a generic equivalent of Hydrea, frequently prescribed in the management of chronic myeloid leukemia (CML), sickle cell anemia, and some head and neck cancers. By inhibiting DNA synthesis in abnormal cells, it helps in reducing the rate of cell growth and improves overall clinical outcomes.

🎬 Educational Video

💉 Dosage & Administration

Note: Dose adjustments may be required based on blood count and kidney function.

⚠️ Side Effects, Warnings & Storage

• 🔄 Common Side Effects: Nausea, loss of appetite, low blood counts, mouth ulcers
• 🚫 Serious Risks: Myelosuppression, secondary leukemia (rare), skin ulcers
• ❄️ Storage: Store below 25°C. Protect from light and moisture
• ⚠️ Precautions: Regular blood monitoring is essential. Avoid in pregnancy and breastfeeding unless directed

🌍 Global Availability & Shipping

Available for international purchase through licensed Indian exporters.

🔗 Related Indian Alternatives (Different Molecules in Same Category)

📚 Trusted External Medical Sources

• FDA – Hydroxyurea Information
• WHO – Model List of Essential Medicines
• Drugs.com – Hydroxyurea
• NHS – Chemotherapy Overview

🩺 Doctor’s Expert Opinion
Dr. Nilesh Mehta, Hematologist-Oncologist:
“Myelostat by Zydus Cadila is an effective generic formulation of Hydroxyurea. It’s widely used in hematologic malignancies and sickle cell management due to its affordability, tolerability, and long-standing clinical efficacy.”

⚠️ Final Medical Disclaimer
This content is intended for informational purposes only. Please consult your healthcare provider before starting, stopping, or modifying any medication.